Effect of sibutramine on regional fat pads and leptin levels in rats fed with three isocaloric diets

European Cytokine Network

Volumn 19, Issue 3, 2008, Pages 149-155

  Stroubini, Theodora ^a   Perrea, Despoina ^a   Perelas, Apostolos ^a   Liapi, Charis ^a   Dontas, Ismini ^a   Trapali, Maria ^a   Katsilambros, Nikolaos ^a   Galanopoulou, Panagiota ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Isocaloric diets perirenal fat epididymal fat; Leptin; Sibutramine

Indexed keywords

LEPTIN; SIBUTRAMINE; ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIPID DIET; LIPID STORAGE; MALE; NONHUMAN; PROTEIN DIET; RAT; WEIGHT REDUCTION; WISTAR RAT; ADIPOSE TISSUE; ANIMAL; BLOOD; DIET; EATING; FAT INTAKE; LIPID METABOLISM; METABOLISM; PROTEIN INTAKE; TIME;

RATTUS; RATTUS NORVEGICUS;

ADIPOSE TISSUE; ANIMALS; APPETITE DEPRESSANTS; CYCLOBUTANES; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; EATING; LEPTIN; LIPID METABOLISM; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 58149399292     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0130     Document Type: Article

References (48)

1. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18: 313.
2. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Ste- houwer CD. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007; 14: 389.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425.
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763.
5. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. JSurgRes2005; 126: 121.
6. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195.
7. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409.
8. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004; 101: 4531.
9. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. NatMed 1995; 1: 1311.
10. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 1997; 121: 1613.
11. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord 1998; 22: S18.
12. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ. Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 1999; 126: 1487.
13. Finer N. Sibutramine: its mode of action and efficacy. Int J Obes Relat Metab Disord 2002; 26: S29.
14. Golozoubova V, Strauss F, Malmlof K. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure. Pharmacol Biochem Behav 2006; 83: 517.
15. Brown M, Bing C, King P, Pickavance L, Heal D, Wilding J. Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypotha- lamic neuropeptide Y. Br J Pharmacol 2001; 132: 1898.
16. Warwick ZS. Probing the causes of high-fat diet hyperphagia: a mechanistic and behavioral dissection. Neurosci Biobehav Rev 1996; 20: 155.
17. Warwick ZS. Dietary fat dose dependently increases spontaneous caloric intake in rat. Obes Res 2003; 11: 859.
18. Warwick ZS, Synowski SJ, Bell KR. Dietary fat content affects energyintakeandweightgainindependentofdietcaloric densityin rats. Physiol Behav 2002; 77: 85.
19. Warwick ZS, Synowski SJ, Rice KD, Smart AB. Independent effects of diet palatability and fat content on bout size and daily intake in rats. Physiol Behav 2003; 80: 253.
20. Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005; 184: 291.
21. Peiser C, McGregor GP, Lang RE. Leptin receptor expression and suppressor of cytokine signaling transcript levels in high-fat-fed rats. Life Sci 2000; 67: 2971.
22. Lopez IP, Milagro FI, Marti A, Moreno-Aliaga MJ, Martinez JA, De Miguel C. High-fatfeeding period affects gene expression in rat white adipose tissue. Mol Cell Biochem 2005; 275: 109.
23. Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high- fat diets lower circulating leptin concentrations in rats. AmJClin Nutr 2000; 71: 438.
24. Lopez IP, Milagro FI, Marti A, Moreno-Aliaga MJ, Martinez JA, De Miguel C. Gene expression changes in rat white adipose tissue after a high-fat diet determined by differential display. Biochem Biophys Res Commun 2004; 318: 234.
25. Masuzaki H, Ogawa Y, Hosoda K, Kawada T, Fushiki T, Nakao K. Augmented expression ofthe obese gene in the adipose tissue from rats fed high-fat diet. Biochem Biophys Res Commun 1995; 216: 355.
26. Archer ZA, Rayner DV, Rozman J, Klingenspor M, Mercer JG. Normal distribution of body weight gain in male Sprague-Dawley rats fed a high-energy diet. Obes Res 2003; 11: 1376.
27. Park ES, Yi SJ, Kim JS, et al. Changes in orexin-A and neuropep- tide Y expression in the hypothalamus of the fasted and high-fat diet fed rats. J Vet Sci 2004; 5: 295.
28. Reda TK, Geliebter A, Pi-Sunyer FX. Amylin, food intake, and obesity. Obes Res 2002; 10: 1087.
29. Boozer CN, Leibel RL, Love RJ, Cha MC, Aronne LJ. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Metabolism 2001; 50: 889.
30. Strack AM, Shu J, Camacho R, et al. Regulation of body weight and carcass composition by sibutramine in rats. Obes Res 2002; 10: 173.
31. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate- treated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim 2000; 49: 239.
32. Levin BE, Dunn-Meynell AA. Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2222.
33. Nonogaki K, Nozue K, Takahashi Y, et al. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptorinactivation induce appetite-suppressing effects in mice via 5-HT1B receptors. Int J Neuropsychopharmacol 2006;7:1.
34. Liu YL, Connoley IP, Harrison J, Heal DJ, Stock MJ. Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors. Eur J Pharmacol 2002; 27: 49.
35. Casado A, Rodriguez VM, Portillo MP, et al. Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins. Nutr Neurosci 2003; 6: 103.
36. Trapali M, Liapi C, Perelas A, et al. Effect of Isocaloric Diets and Sibutramine on Food Intake, Body Mass Variation and Serum TNF-alpha Levels in Rats. Pharmacology 2008; 82: 15.
37. Faria AN, Ribeiro Filho FF, Kohlmann NE, Gouvea Ferreira SR, Zanella MT. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients. Diabetes Obes Metab 2005; 7: 246.
38. Kim DM, Yoon SJ, Ahn CW, et al. Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. Diabetes Res Clin Pract 2004; 66: S139.
39. Sanchez-Reyes L, Fanghanel G, Yamamoto J, Martinez-Rivas L, Campos-Franco E, Berber A. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial. Clin Ther 2004; 26: 1427.
40. Van Gaal LF, Wauters MA, Peiffer FW, De Leeuw IH. Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal/visceral fat reduction? Int J Obes Relat Metab Disord 1998; 22: S38.
41. Yoshioka K, Katoh K, Hayashi H, Mashiko T, Obara Y. Oral administration of uridylic acid increases plasma leptin, but suppresses glucose and non-esterified fatty acid concentrations in rats. Life Sci 2006; 79: 532.
42. Sakono M, Yuji K, Miyanaga F, et al. Combined effects of dietary conjugated linoleic acid and sesamin triacylglycerol and ketone body production in rat liver. J Nutr Sci Vitaminol (Tokyo) 2002; 48: 405.
43. Takeuchi H, Kubota F, Itakura M, Taguchi N. Effect oftriacylglyc- erols containing medium- and long-chain fatty acids on body fat accumulation in rats. J Nutr Sci Vitaminol (Tokyo) 2001; 47: 267.
44. Caserta F, Tchkonia T, Civelek VN, et al. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol 2001; 280: E238.
45. Kirkland JL, Hollenberg CH, Gillon WS. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int J Obes Relat Metab Disord 1996; 20: S102.
46. Giordano A, Centemeri C, Zingaretti MC, Cinti S. Sibutramine- dependent brown fat activation in rats: an immunohistochemical study. Int J Obes Relat Metab Disord 2002; 26: 354.
47. Ortmann S, Kampe J, Gossel M, et al. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. Obes Res 2004; 12: 1290.
48. Bush EN, Shapiro R, Brune ME, et al. Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet- induced obese mice. Endocrine 2006; 29: 375.